FDA extends Blenrep combo review to October to assess more data from Phase 3 trials in relapsed or refractory multiple myeloma.

The EU approves belantamab mafodotin combinations, enhancing treatment options for relapsed multiple myeloma patients with ...

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory ...

Despite the setback with the Oncologic Drugs Advisory Committee vote, GSK emphasizes the unmet need in multiple myeloma and ...

GoodRx will pay $25 million to settle claims it shared users’ sensitive data with third parties like Meta and Google without ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today provides an update on its commercial and operational ...

Q2 2025 Earnings Call Transcript July 22, 2025 Operator: Good day, and welcome to the Alexandria Real Estate Equities Second ...

Low energy, poor physical performance, and weak muscles make you feel old and tired. The good news is that there are supplements with natural ingredients that m ...

Intravenous fosfomycin (IVFOF) is becoming increasingly utilized for the treatment of severe infections; however, its broader adoption is often limited by ...

Nigerian importers may experience a reduction in duty pay as the Nigeria Customs Service plans to scrap the one per cent Comprehensive Import Supervision Scheme and seven per cent Cost of Collection ...

The field of oncology has been revolutionized by the introduction of immune checkpoint inhibitors, with anti-PD-1 therapies offering durable responses in ...

CMS issued the 2026 Medicare Physician Fee Schedule, or PFS, proposed rule on July 14.It includes a 0.75% increase to the ...